| 2025-12-05 |
详情>>
内部人交易：
Wedel Christensen Jakob共交易2笔
|
| 2025-10-31 |
详情>>
股本变动：
变动后总股本15280.00万股
|
| 2025-10-31 |
详情>>
业绩披露：
2025年三季报(累计)每股收益3.30美元,归母净利润5.16亿美元,同比去年增长136.60%
|
| 2025-10-30 |
财报披露：
美东时间 2025-10-30 盘后发布财报
|
| 2025-08-01 |
详情>>
业绩披露：
2025年中报每股收益2.32美元,归母净利润3.66亿美元,同比去年增长117.31%
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益0.83美元,归母净利润1.31亿美元,同比去年增长203.97%
|
| 2025-04-09 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.Elect eleven nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2025;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the accompanying proxy statement;
4.Hold a vote to approve the Second Amended and Restated 2015 Stock and Incentive Plan of Illumina, Inc.;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2025-02-12 |
详情>>
业绩披露：
2024年年报每股收益-7.69美元,归母净利润-12.23亿美元,同比去年增长-5.34%
|
| 2025-02-12 |
详情>>
业绩披露：
2022年年报每股收益-28美元,归母净利润-44.04亿美元,同比去年增长-677.95%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-8.86美元,归母净利润-14.1亿美元,同比去年增长-43%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-1.46美元,归母净利润-2.31亿美元,同比去年增长48.55%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-13.28美元,归母净利润-21.14亿美元,同比去年增长-815.15%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年一季报每股收益-0.79美元,归母净利润-1.26亿美元,同比去年增长-4300%
|
| 2024-04-04 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.Elect eleven nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2024;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the accompanying proxy statement;
4.Transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2024-02-16 |
详情>>
业绩披露：
2023年年报每股收益-7.34美元,归母净利润-11.61亿美元,同比去年增长73.64%
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-6.23美元,归母净利润-9.86亿美元,同比去年增长76.88%
|
| 2023-04-20 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Elect nine nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on the frequency of holding an advisory vote to approve compensation provided to our “named executive officers”;
5.Hold a vote to approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2023-04-20 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Elect nine nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on the frequency of holding an advisory vote to approve compensation provided to our “named executive officers”;
5.Hold a vote to approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2022-04-14 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.Elect the nine nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal regarding the right of stockholders to call special meetings;
5.Hold a vote to approve an amendment and restatement of our Certificate of Incorporation to permit stockholders to call special meetings;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-16 |
股东大会：
将于2021-05-26召开股东大会
会议内容 ▼▲
- 1.Elect the four nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2021;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal regarding political disclosures;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2020-09-21 |
复牌提示：
2020-09-21 06:55:10 停牌，复牌日期 2020-09-21 07:20:00
|
| 2020-04-16 |
股东大会：
将于2020-05-27召开股东大会
会议内容 ▼▲
- 1.Elect the four nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2021;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal regarding political disclosures;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2019-04-16 |
股东大会：
将于2019-05-29召开股东大会
会议内容 ▼▲
- 1.Elect the three nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2019;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold a vote to approve an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors;
5.Hold an advisory vote on a stockholder proposal to enhance election-related disclosures;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2018-04-06 |
股东大会：
将于2018-05-23召开股东大会
会议内容 ▼▲
- 1.Elect the three nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal to elect each director annually;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2017-04-14 |
股东大会：
将于2017-05-30召开股东大会
会议内容 ▼▲
- 1.Elect the three nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on the frequency of future advisory votes to approve the compensation of our “named executive officers”;
5.Hold a vote to approve an amendment to our certificate of incorporation to remove certain supermajority voting requirements;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2016-04-08 |
股东大会：
将于2016-05-18召开股东大会
会议内容 ▼▲
- 1. Elect the three nominees named in the proxy statement to our Board of Directors;
2. Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2017;
3. Hold an advisory vote to approve the compensation of the “named executive officers” as disclosed in the proxy statement;
4. Hold an advisory vote to ratify certain supermajority voting provisions in our certificate of incorporation and bylaws;
5. Transact such other business as may properly come before the meeting and any adjournment or postponement.
|